United States· US:10967-686_471d8e2d-4be4-6180-e063-6394a90ac721
Prevage anti aging SPF 30
A medicinal product containing octinoxate; octocrylene; octisalate; avobenzone; oxybenzone, registered in United States by Revlon.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OCTINOXATE; OCTOCRYLENE; OCTISALATE; AVOBENZONE; OXYBENZONE
- Manufacturer
- Revlon
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11109676861750 mL in 1 TUBE (10967-686-17)
- ndc1110967-686-17
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/78c84576-1c50-4ea5-b3d1-af9f397ee723 GET /v1/drugs/78c84576-1c50-4ea5-b3d1-af9f397ee723?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "7.5; 2.2; 5; 2; 5",
"substance": "OCTINOXATE; OCTOCRYLENE; OCTISALATE; AVOBENZONE; OXYBENZONE",
"productndc": "10967-686",
"dosage_form": "LOTION",
"dea_schedule": null,
"strength_unit": "g/mL; mg/mL; mg/mL; mg/mL; mg/mL",
"application_number": "M020",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about octinoxate; octocrylene; octisalate; avobenzone; oxybenzone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.